Illumina (NASDAQ:ILMN – Get Free Report)‘s stock had its “outperform” rating restated by equities research analysts at Evercore ISI in a note issued to investors on Friday, Benzinga reports. They currently have a $240.00 price target on the life sciences company’s stock. Evercore ISI’s target price suggests a potential upside of 42.47% from the stock’s […]